Costs and clinical outcomes of noninvasive fetal RhD typing for targeted prophylaxis.

@article{Hawk2013CostsAC,
  title={Costs and clinical outcomes of noninvasive fetal RhD typing for targeted prophylaxis.},
  author={Angela F Hawk and Eugene Y. Chang and Sally M Shields and Kit N. Simpson},
  journal={Obstetrics and gynecology},
  year={2013},
  volume={122 3},
  pages={
          579-85
        }
}
OBJECTIVE To examine the cost and clinical outcomes of noninvasive RhD typing with cell-free fetal DNA to selectively deliver antenatal and postnatal prophylaxis with anti-D immune globulin for prevention of alloimmunization in RhD-negative women. METHODS We developed a decision tree to compare the costs and clinical outcomes of three strategies in an RhD-negative nonalloimmunized population as follows: 1) routine antenatal anti-D immune globulin prophylaxis and postpartum prophylaxis guided… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 11 times. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-6 of 6 extracted citations

William W. Pollack, PhD: a pioneer in perinatology.

Obstetrics and gynecology • 2014
View 1 Excerpt